|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

Divisions of
*
Allergy and
Immunochemistry, La Jolla Institute for Allergy and Immunology, San Diego, CA 92121
Glycosylation-inhibiting factor (GIF) is a 13-kDa cytokine secreted
from T cells. Administration of bioactive recombinant GIF inhibits IgG1
and IgE Ab responses in vivo. Treatment of B cells with the cytokine
reduces the secretion of IgG1 and IgE induced by LPS and IL-4. To
examine the effect on cognate T-B interaction, GIF was added to
low-density B cells from MD4 transgenic (Tg) mice, which express B cell
receptor specific for hen egg lysozyme (HEL). The B cells were
subsequently pulsed with HEL-OVA conjugate and cultured with
OVA-specific naive CD4 T cells from DO11.10 Tg mice. Treatment of
Ag-presenting B cells with GIF reduced expansion and IL-2 secretion of
naive T cells and rendered them hyporesponsive to antigenic
restimulation, resulting in 5095% reduction of IL-4 and IFN-
secretion upon restimulation with Ag. GIF dramatically inhibited Th
effector generation when it was added to B cells before pulsing with
HEL-OVA, whereas it showed little to no effect when added after B cells
were pulsed with Ag. GIF was more effective when B cells from MD4 Tg
mice were pulsed with HEL-OVA than when they were pulsed with OVA. This
cytokine did not affect Th effector generation when B cells or
irradiated splenocytes pulsed with OVA323339 peptide
stimulated naive DO11.10 T cells. Confocal microscopy revealed that GIF
inhibited internalization of HEL by B cells from MD4 Tg mice.
Therefore, the cytokine may regulate early steps of Ag presentation
involving B cell receptors to diminish Th effector generation from
naive CD4 T cells.
This article has been cited by other articles:
![]() |
M. Kim-Saijo, E. M. Janssen, and K. Sugie CD4 cell-secreted, posttranslationally modified cytokine GIF suppresses Th2 responses by inhibiting the initiation of IL-4 production PNAS, December 9, 2008; 105(49): 19402 - 19407. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ronet, H. Voigt, H. Himmelrich, M.-A. Doucey, Y. Hauyon-La Torre, M. Revaz-Breton, F. Tacchini-Cottier, C. Bron, J. Louis, and P. Launois Leishmania major-Specific B Cells Are Necessary for Th2 Cell Development and Susceptibility to L. major LV39 in BALB/c Mice J. Immunol., April 1, 2008; 180(7): 4825 - 4835. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Hizawa, E. Yamaguchi, D. Takahashi, J. Nishihira, and M. Nishimura Functional Polymorphisms in the Promoter Region of Macrophage Migration Inhibitory Factor and Atopy Am. J. Respir. Crit. Care Med., May 1, 2004; 169(9): 1014 - 1018. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Shirota, K. Sano, N. Hirasawa, T. Terui, K. Ohuchi, T. Hattori, and G. Tamura B Cells Capturing Antigen Conjugated with CpG Oligodeoxynucleotides Induce Th1 Cells by Elaborating IL-12 J. Immunol., July 15, 2002; 169(2): 787 - 794. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |